Prot# GED-0301-CD-002: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Subjects with Active Crohn’s Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date2/22/172/22/20

Funding

  • Celgene Corporation (GED-0301-CD-002)